Shun Kaneko, Yasuhiro Asahina, Miyako Murakawa, Seishin Azuma, Kento Inada, Tomohiro Mochida, Keiya Watakabe, Taro Shimizu, Jun Tsuchiya, Masato Miyoshi, Fukiko Kawai-Kitahata, Sayuri Nitta, Marie Takahashi, Tomoyuki Fujioka, Mitsuhiro Kishino, Tatsuhiko Anzai, Sei Kakinuma, Mina Nakagawa, Ryuichi Okamoto. Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades. PLoS One. 2024; 19 (3): e0297882. ( PubMed, DOI )

Kirino Sakura, Tamaki Nobuharu, Kurosaki Masayuki, Takahashi Yuka, Higuchi Mayu, Itakura Yoshie, Tanaka Yuki, Inada Kento, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Hayakawa Yuka, Kakegawa Tatsuya, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Okamoto Ryuichi, Izumi Namiki. Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population QUANTITATIVE IMAGING IN MEDICINE AND SURGERY. 2023.08; 13 (10): 6493-6502. ( PubMed, DOI )

Kaneko Shun, Asahina Yasuhiro, Nakagawa Mina, Murakawa Miyako, Miyazaki Yasunari, Asakage Takahiro, Fukuda Shohei, Namiki Takeshi, Kano Yoshihito, Nagata Masashi, Tsuchiya Jun, Miyoshi Masato, Kitahata-Kawai Fukiko, Nitta Sayuri, Itsui Yasuhiro, Kakinuma Sei, Okamoto Ryuichi. 免疫チェックポイント阻害薬による治療が実施された進行癌患者における肝障害および予後関連因子(Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors) Hepatology Research. 2023.05; 53 (5): 450-459. ( ichushi )

Yuka Hayakawa, Nobuharu Tamaki, Hiroyuki Nakanishi, Masayuki Kurosaki, Yuki Tanaka, Kento Inada, Shun Ishido, Sakura Kirino, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Ryuichi Okamoto, Namiki Izumi. Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy. Internal Medicine. 2023.04; 62 (7): 973-978. ( PubMed, DOI )

Taisei Keitoku, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Shun Ishido, Michiko Yamada, Tsubasa Nobusawa, Hiroaki Matsumoto, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yasuhiro Asahina, Ryuichi Okamoto, Namiki Izumi. Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy. J Viral Hepat. 2023.04; 30 (4): 297-302. ( PubMed, DOI )

Hayakawa Yuka, Tamaki Nobuharu, Nakanishi Hiroyuki, Kurosaki Masayuki, Tanaka Yuki, Inada Kento, Ishido Shun, Kirino Sakura, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Takahashi Yuka, Tsuchiya Kaoru, Okamoto Ryuichi, Izumi Namiki. 治療抵抗性肝性脳症に対するリファキシミン追加投与の効果(Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy) Internal Medicine. 2023.04; 62 (7): 973-978. ( ichushi )

Tetsuro Shimakami, Hiroko Setoyama, Noriko Oza, Jun Itakura, Shun Kaneko, Masaaki Korenaga, Tadashi Toyama, Junko Tanaka, Tatsuya Kanto. Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan. J Gastroenterol. 2023.03; 58 (3): 257-267. ( PubMed, DOI )

Shimakami Tetsuro, Setoyama Hiroko, Oza Noriko, Itakura Jun, Kaneko Shun, Korenaga Masaaki, Toyama Tadashi, Tanaka Junko, Kanto Tatsuya. 日本における肝癌予防の評価および推進ツールとしての肝炎対策のためのパフォーマンス指標の開発(Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan) Journal of Gastroenterology. 2023.03; 58 (3): 257-267. ( ichushi )

Shun Kaneko, Yasuhiro Asahina, Mina Nakagawa, Miyako Murakawa, Yasunari Miyazaki, Takahiro Asakage, Shohei Fukuda, Takeshi Namiki, Yoshito Kano, Masashi Nagata, Jun Tsuchiya, Masato Miyoshi, Fukiko Kitahata-Kawai, Sayuri Nitta, Yasuhiro Itsui, Sei Kakinuma, Ryuichi Okamoto. Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors. Hepatol Res. 2023.01; 53 (5): 450-459. ( PubMed, DOI )

Shun Kaneko, Masayuki Kurosaki, Toshie Mashiba, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Yasushi Uchida, Hideki Fujii, Takehiro Akahane, Hitoshi Yagisawa, Atsunori Kusakabe, Haruhiko Kobashi, Takehiko Abe, Hideo Yoshida, Chikara Ogawa, Koichiro Furuta, Nobuharu Tamaki, Keiji Tsuji, Tomomichi Matsushita, Namiki Izumi, . Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B. J Med Virol. 2023.01; 95 (1): e28210. ( PubMed, DOI )

Sakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, Shun Kaneko, Kento Inada, Yuki Tanaka, Shun Ishido, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Yuka Hayakawa, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Ryuichi Okamoto, Namiki Izumi. Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B. Hepatol Res. 2023.01; 53 (1): 35-42. ( PubMed, DOI )

Shokichi Takahama, Sachiyo Yoshio, Yuji Masuta, Hirotomo Murakami, Ryotaro Sakamori, Shun Kaneko, Takashi Honda, Miyako Murakawa, Masaya Sugiyama, Masayuki Kurosaki, Yasuhiro Asahina, Tetsuo Takehara, Victor Appay, Tatsuya Kanto, Takuya Yamamoto. Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality Front Immunol. 2023; 14 1257113. ( PubMed, DOI )

Shun Kaneko, Masayuki Kurosaki, Akemi Kurisu, Tomoyuki Akita, Junko Tanaka, Tatsuya Kanto. Impact of antiviral therapy for disease progression and non-invasive liver fibrosis index in patients with chronic hepatitis C: Markov chain model analysis. Hepatology Research. 2022.08; 52 (8): 665-676. ( PubMed, DOI )

Kaneko Shun, Kurosaki Masayuki, Kurisu Akemi, Akita Tomoyuki, Tanaka Junko, Kanto Tatsuya. 慢性C型肝炎患者への抗ウイルス療法によって疾患進行および非侵襲的肝線維化指数に現れる影響　マルコフ連鎖モデル解析(Impact of antiviral therapy for disease progression and non-invasive liver fibrosis index in patients with chronic hepatitis C: Markov chain model analysis) Hepatology Research. 2022.08; 52 (8): 665-676. ( ichushi )

Kaneko S, Tsuchiya K, Yasui Y, Tanaka Y, Inada K, Ishido S, Kirino S, Yamashita K, Hayakawa Y, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Takahashi Y, Nakanishi H, Irie T, Ariizumi SI, Kurosaki M, Izumi N. Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment. JGH open : an open access journal of gastroenterology and hepatology. 2022.05; 6 (5): 301-308. ( PubMed, DOI )

Shun Kaneko , Kaoru Tsuchiya , Yutaka Yasui , Yuki Tanaka , Kento Inada , Shun Ishido , Sakura Kirino , Koji Yamashita , Yuka Hayakawa , Tsubasa Nobusawa , Hiroaki Matsumoto , Tatsuya Kakegawa , Mayu Higuchi , Kenta Takaura , Shohei Tanaka , Chiaki Maeyashiki , Nobuharu Tamaki , Yuka Takahashi , Hiroyuki Nakanishi , Takumi Irie , Shun-Ichi Ariizumi , Masayuki Kurosaki , Namiki Izumi . Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment. JGH Open. 2022.04; 6 (5): 301-308.

Shun Kaneko, Masayuki Kurosaki, Kaoru Tsuchiya, Yutaka Yasui, Yuka Hayakawa, Kento Inada, Yuki Tanaka, Shun Ishido, Sakura Kirino, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Yuka Takahashi, Hiroyuki Nakanishi, Namiki Izumi. Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma. PLoS One. 2022.03; 17 (3): e0265235. ( PubMed, DOI )

Shuhei Sekiguchi, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Ryuichi Okamoto, Masayuki Kurosaki, Namiki Izumi. Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy.(Online ahead of print.) Cancer Rep (Hoboken). 2022.03; e1613. ( PubMed, DOI )

Higuchi M, Tamaki N, Kurosaki M, Inada K, Kirino S, Yamashita K, Hayakawa Y, Osawa L, Takaura K, Maeyashiki C, Kaneko S, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Itakura J, Loomba R, Enomoto N, Izumi N.. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality Aliment Pharmacol Ther.. 2022.02; 55 (3): 292-301.

Kaneko S, Kurosaki M, Sugiyama T, Takahashi Y, Yamaguchi Y, Nagasawa M, Izumi N.. The dynamics of quantitative SARS-CoV-2 antispike IgG response to BNT162b2 vaccination J Med Virol. 2021.12; 93 (12): 6813-6817.

Kaneko S, Kurosaki M, Inada K, Kirino S, Hayakawa Y, Yamashita K, Osawa L, Sekiguchi S, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Itakura J, Takahashi Y, Tsuchiya K, Nakanishi H, Izumi N.. Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients J Gastroenterol Hepatol. 2021.10; 36 (10): 2943-2951.

Inada K, Kaneko S, Kurosaki M, Yamashita K, Kirino S, Osawa L, Hayakawa Y, Sekiguchi S, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Itakura J, Takahashi Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N. Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis. JGH open : an open access journal of gastroenterology and hepatology. 2021.09; 5 (9): 1085-1091. ( PubMed, DOI )

Kaneko S, Kurosaki M, Tsuchiya K, Yasui Y, Inada K, Kirino S, Yamashita K, Osawa L, Hayakawa Y, Sekiguchi S, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Itakura J, Takahashi Y, Nakanishi H, Asano D, Irie T, Kawachi Y, Izumi N.. Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade Hepatol Res. 2021.08; 51 (8): 902-908.

Inada K, Kaneko S, Kurosaki M, Yamashita K, Kirino S, Osawa L, Hayakawa Y, Sekiguchi S, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Itakura J, Takahashi Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N.. Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis. JGH Open. 2021.08; 19 (5): 1085-1091.

Kaneko Shun, Kurosaki Masayuki, Tsuchiya Kaoru, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Itakura Jun, Takahashi Yuka, Nakanishi Hiroyuki, Asano Daisuke, Irie Takumi, Kawachi Yasuyuki, Izumi Namiki. アルブミン-ビリルビングレードにより層別化した肝内胆管癌の予後(Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade) Hepatology Research. 2021.08; 51 (8): 902-908. ( ichushi )

Higuchi M, Tamaki N, Kurosaki M, Inada K, Kirino S, Yamashita K, Hayakawa Y, Sekiguchi S, Osawa L, Takaura K, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Enomoto N, Izumi N. Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis C. Journal of medical virology. 2021.06; 93 (6): 3744-3751. ( PubMed, DOI )

Kaneko S, Nukui Y, Arashiro T, Aiso Y, Sugii M, Hadano Y, Nagata K, Taki R, Ueda K, Hanada S, Suzaki S, Harada N, Yamaguchi Y, Nakanishi H, Kurosaki M, Nagasawa M, Izumi N. Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort J Med Virol. 2021.01; 93 (1): 569-572.

Kaneko S, Nukui Y, Arashiro T, Aiso Y, Sugii M, Hadano Y, Nagata K, Taki R, Ueda K, Hanada S, Suzaki S, Harada N, Yamaguchi Y, Nakanishi H, Kurosaki M, Nagasawa M, Izumi N. Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort. Journal of medical virology. 2021.01; 93 (1): 569-572. ( PubMed, DOI )

Kaneko S, Tsuchiya K, Yasui Y, Inada K, Kirino S, Yamashita K, Osawa L, Hayakawa Y, Sekiguchi S, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Takeguchi T, Takeguchi Y, Nagano T, Nakanishi H, Itakura J, Takahashi Y, Himeno Y, Hoshi A, Kurosaki M, Izumi N. Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis Hepatol Res. 2020.12; 50 (12): 1375-1385.

Tamaki N, Kurosaki M, Takahashi Y, Itakura Y, Kirino S, Inada K, Yamashita K, Sekiguchi S, Hayakawa Y, Osawa L, Higuchi M, Takaura K, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Loomba R, Izumi N. <i>Wisteria floribunda</i> Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup. International journal of molecular sciences. 2020.12; 22 (1): ( PubMed, DOI )

Kaneko Shun, Tsuchiya Kaoru, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Takeguchi Takaya, Takeguchi Yuko, Nagano Takuya, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Himeno Yoshiro, Hoshi Akihiko, Kurosaki Masayuki, Izumi Namiki. 肝機能と門脈腫瘍血栓症に基づく進行肝細胞癌に対する戦略(Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis) Hepatology Research. 2020.12; 50 (12): 1375-1385. ( ichushi )

Kaneko S, Kurosaki M, Nagata K, Taki R, Ueda K, Hanada S, Takayama K, Suzaki S, Harada N, Sugiyama T, Nagasawa M, Izumi N.. Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity PLoS One. 2020.11; 15 (11): ( DOI )

Kaneko S, Kurosaki M, Joko K, Marusawa H, Kondo M, Kojima Y, Uchida Y, Kimura H, Tsuji K, Yagisawa H, Kusakabe A, Kobashi H, Akahane T, Tamaki N, Kirino S, Abe T, Yoshida H, Matsushita T, Hasebe C, Izumi N.. Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score Sci Rep. 2020.08; 10 (1): ( DOI )

Kaneko S, Kurosaki M, Joko K, Marusawa H, Kondo M, Kojima Y, Uchida Y, Kimura H, Tsuji K, Yagisawa H, Kusakabe A, Kobashi H, Akahane T, Tamaki N, Kirino S, Abe T, Yoshida H, Matsushita T, Hasebe C, Izumi N. Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score. Scientific reports. 2020.08; 10 (1): 13021. ( PubMed, DOI )

Tamaki N, Kurosaki M, Nakanishi H, Itakura J, Inada K, Kirino S, Yamashita K, Osawa L, Sekiguchi S, Hayakawa Y, Wang W, Okada M, Higuchi M, Takaura K, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Takahashi Y, Izumi N. Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B. Journal of medical virology. 2020.08; 92 (8): 1355-1358. ( PubMed, DOI )

Tamaki Nobuharu, Kurosaki Masayuki, Higuchi Mayu, Kirino Sakura, Inada Kento, Yamashita Koji, Sekiguchi Shuhei, Hayakawa Yuka, Osawa Leona, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Izumi Namiki. 進行性線維症患者に対する内視鏡スクリーニング回避を目的としたアルブミン、ビリルビン、血小板基準の検証(Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis) Hepatology Research. 2020.08; 50 (8): 996-999. ( ichushi )

Sato A, Kakinuma S, Miyoshi M, Kamiya A, Tsunoda T, Kaneko S, Tsuchiya J, Shimizu T, Takeichi E, Nitta S, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Koshikawa N, Seiki M, Nakauchi H, Asahina Y, Watanabe M. Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts. Hepatology communications. 2020.02; 4 (2): 235-254. ( PubMed, DOI )

Kaneko Shun, Tsuchiya Kaoru, Kurosaki Masayuki, Kirino Sakura, Inada Kento, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Watakabe Keiya, Okada Mao, Wang Wan, Shimizu Takao, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Takeguchi Takaya, Takeguchi Yuko, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Himeno Yoshiro, Izumi Namiki. レンバチニブ投与下の肝細胞癌患者の生存に関する画像効果判定の3基準(Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib) Hepatology Research. 2020.01; 50 (1): 137-143. ( ichushi )

Kirino S, Tsuchiya K, Kurosaki M, Kaneko S, Inada K, Yamashita K, Osawa L, Hayakawa Y, Sekiguchi S, Okada M, Wang W, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Izumi N. Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma. PloS one. 2020; 15 (4): e0231828. ( PubMed, DOI )

Kawai-Kitahata Fukiko, Asahina Yasuhiro, Kaneko Shun, Tsuchiya Jun, Sato Ayako, Miyoshi Masato, Tsunoda Tomoyuki, Inoue-Shinomiya Emi, Murakawa Miyako, Nitta Sayuri, Itsui Yasuhiro, Nakagawa Mina, Azuma Seishin, Kakinuma Sei, Tanabe Minoru, Sugawara Emiko, Takemoto Akira, Ojima Hidenori, Sakamoto Michiie, Muraoka Masaru, Takano Shinichi, Maekawa Shinya, Enomoto Nobuyuki, Watanabe Mamoru. 肝細胞癌様領域と異時性肝細胞癌が併存する胆管細胞癌の網羅的遺伝子解析(Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma-like area and metachronous hepatocellular carcinoma) Hepatology Research. 2019.12; 49 (12): 1466-1474. ( ichushi )

Wan Wang, Kaoru Tsuchiya, Masayuki Kurosaki, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mao Okada, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi. Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice. Cancers (Basel). 2019.10; 11 (10): ( PubMed, DOI )

Takada H, Kurosaki M, Tsuchiya K, Komiyama Y, Itakura J, Takahashi Y, Nakanishi H, Yasui Y, Tamaki N, Maeyashiki C, Kaneko S, Takaura K, Higuchi M, Okada M, Wang W, Osawa L, Sekiguchi S, Hayakawa Y, Yamashita K, Enomoto N, Izumi N. Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma. Cancers. 2019.08; 11 (9): ( PubMed, DOI )

Shun Kaneko, Kaoru Tsuchiya, Masayuki Kurosaki, Sakura Kirino, Kento Inada, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Keiya Watakabe, Mao Okada, Wang Wan, Takao Shimizu, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Takaya Takeguchi, Yuko Takeguchi, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yoshiro Himeno, Namiki Izumi. The three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib. Hepatol. Res.. 2019.07; ( PubMed, DOI )

Nobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, Sakura Kirino, Leona Osawa, Keiya Watakabe, Wan Wang, Mao Okada, Takao Shimizu, Kenta Takaura, Hitomi Takada, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Nobuyuki Enomoto, Namiki Izumi. Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals. J. Viral Hepat.. 2019.07; 26 (7): 893-899. ( PubMed, DOI )

Nobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, Sakura Kirino, Leona Osawa, Keiya Watakabe, Wan Wang, Mao Okada, Takao Shimizu, Kenta Takaura, Hitomi Takada, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Nobuyuki Enomoto, Namiki Izumi. Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease. Sci Rep. 2019.07; 9 (1): 10109. ( PubMed, DOI )

Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shun Kaneko, Jun Tsuchiya, Ayako Sato, Masato Miyoshi, Tomoyuki Tsunoda, Emi Inoue-Shinomiya, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Sei Kakinuma, Minoru Tanabe, Emiko Sugawara, Akira Takemoto, Hidenori Ojima, Michiie Sakamoto, Masaru Muraoka, Shinichi Takano, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe. Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma-like area and metachronous hepatocellular carcinoma. Hepatol. Res.. 2019.07; 49 (12): 1466-1474. ( PubMed, DOI )

Shun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, Jun Itakura, Tsuguru Hayashi, Sakura Kirino, Leona Osawa, Keiya Watakabe, Mao Okada, Wan Wang, Takao Shimizu, Mayu Higuchi, Kenta Takaura, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yuka Takahashi, Mamoru Watanabe, Namiki Izumi. Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate. J. Gastroenterol. Hepatol.. 2019.04; 34 (11): 2004-2010. ( PubMed, DOI )

Tomoyuki Tsunoda, Sei Kakinuma, Masato Miyoshi, Akihide Kamiya, Shun Kaneko, Ayako Sato, Jun Tsuchiya, Sayuri Nitta, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Tsuyoshi Sogo, Haruki Komatsu, Ryutaro Mukouchi, Ayano Inui, Tomoo Fujisawa, Hiromitsu Nakauchi, Yasuhiro Asahina, Mamoru Watanabe. Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium. J. Hepatol.. 2019.03; 71 (1): 143-152. ( PubMed, DOI )

Miyoshi M, Kakinuma S, Kamiya A, Tsunoda T, Tsuchiya J, Sato A, Kaneko S, Nitta S, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Nakauchi H, Asahina Y, Watanabe M. LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells. Scientific reports. 2019.02; 9 (1): 2072. ( PubMed, DOI )

Seishin Azuma, Yasuhiro Asahina, Sei Kakinuma, Keiko Azuma, Masato Miyoshi, Emi Inoue, Tomoyuki Tsunoda, Ayako Sato, Shun Kaneko, Hiroko Nagata, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Makoto Tomita, Mina Nakagawa, Mamoru Watanabe. Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Dig Dis. 2019; 37 (3): 247-254. ( PubMed, DOI )

Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, Keiya Watakabe, Leona Osawa, Wan Wang, Mao Okada, Takao Shimizu, Kenta Takaura, Hitomi Takada, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Namiki Izumi. Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance Elastography. Clin. Gastroenterol. Hepatol.. 2018.11; ( PubMed, DOI )

Murakawa Miyako, Asahina Yasuhiro, Nagata Hiroko, Nakagawa Mina, Kakinuma Sei, Nitta Sayuri, Kawai-Kitahata Fukiko, Otani Satoshi, Kaneko Shun, Miyoshi Masato, Tsunoda Tomoyuki, Asano Yu, Sato Ayako, Itsui Yasuhiro, Azuma Seishin, Nouchi Toshihiko, Furumoto Yohei, Asano Tooru, Chuganji Yoshimichi, Tohda Shuji, Watanabe Mamoru. ソホスブビル+リバビリン治療を行ったC型慢性肝炎ジェノタイプ2患者におけるITPA遺伝的変異とリバビリン誘発性貧血(ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin) Hepatology Research. 2017.10; 47 (11): 1212-1218. ( ichushi )

Goto Fumio, Kakinuma Sei, Miyoshi Masato, Tsunoda Tomoyuki, Kaneko Shun, Sato Ayako, Asano Yu, Otani Satoshi, Azuma Seishin, Nagata Hiroko, Kawai-Kitahata Fukiko, Murakawa Miyako, Nitta Sayuri, Itsui Yasuhiro, Nakagawa Mina, Asahina Yasuhiro, Watanabe Mamoru. 骨形成因子4は胎児肝幹/前駆細胞の増殖と最終分化を調整する(Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells) Hepatology Research. 2017.08; 47 (9): 941-952. ( ichushi )

Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Ayako Sato, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Shun Kaneko, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Toshihiko Nouchi, Hideki Sakai, Makoto Tomita, Mamoru Watanabe, . Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C. J. Hepatol.. 2017.06; 67 (5): 933-939. ( PubMed, DOI )

Miyako Murakawa, Yasuhiro Asahina, Hiroko Nagata, Mina Nakagawa, Sei Kakinuma, Sayuri Nitta, Fukiko Kawai-Kitahata, Satoshi Otani, Shun Kaneko, Masato Miyoshi, Tomoyuki Tsunoda, Yu Asano, Ayako Sato, Yasuhiro Itsui, Seishin Azuma, Toshihiko Nouchi, Yohei Furumoto, Tooru Asano, Yoshimichi Chuganji, Shuji Tohda, Mamoru Watanabe. ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin. Hepatol. Res.. 2017.01; 47 (11): 1212-1218. ( PubMed, DOI )

Miyako Murakawa, Yasuhiro Asahina, Fukiko Kawai-Kitahata, Mina Nakagawa, Sayuri Nitta, Satoshi Otani, Hiroko Nagata, Shun Kaneko, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Yasuhito Tanaka, Sayuki Iijima, Kaoru Tsuchiya, Namiki Izumi, Shuji Tohda, Mamoru Watanabe. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. [Epub ahead of print] J. Med. Virol. 2016.12; 89 (7): 1241-1247. ( PubMed, DOI )

Fumio Goto, Sei Kakinuma, Masato Miyoshi, Tomoyuki Tsunoda, Shun Kaneko, Ayako Sato, Yu Asano, Satoshi Otani, Seishin Azuma, Hiroko Nagata, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Mina Nakagawa, Yasuhiro Asahina, Mamoru Watanabe. Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells. Hepatol. Res. 2016.09; 47 (9): 941-952. ( PubMed, DOI )

Hiroko Nagata, Mina Nakagawa, Yuki Nishimura-Sakurai, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Shun Kaneko, Fumio Goto, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Naoko Tojo, Shuji Tohda, Yasuhiro Asahina, Mamoru Watanabe, . Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy.[Epub ahead of print] Hepatol Int. 2016.07; ( PubMed, DOI )

Shun Kaneko, Sei Kakinuma, Yasuhiro Asahina, Akihide Kamiya, Masato Miyoshi, Tomoyuki Tsunoda, Sayuri Nitta, Yu Asano, Hiroko Nagata, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Hiromitsu Nakauchi, Hironori Nishitsuji, Saneyuki Ujino, Kunitada Shimotohno, Masashi Iwamoto, Koichi Watashi, Takaji Wakita, Mamoru Watanabe. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus. Sci Rep. 2016.07; 6 29358. ( PubMed, DOI )

Miki Taniguchi, Megumi Tasaka-Fujita, Mina Nakagawa, Takako Watanabe, Fukiko Kawai-Kitahata, Satoshi Otani, Fumio Goto, Hiroko Nagata, Shun Kaneko, Sayuri Nitta, Miyako Murakawa, Yuki Nishimura-Sakurai, Seishin Azuma, Yasuhiro Itsui, Kenichi Mori, Shintaro Yagi, Sei Kakinuma, Yasuhiro Asahina, Mamoru Watanabe. Evaluation of Interferon Resistance in Newly Established Genotype 1b Hepatitis C Virus Cell Culture System. J Clin Transl Hepatol. 2016.03; 4 (1): 5-11. ( PubMed, DOI )

Satoshi Otani, Sei Kakinuma, Akihide Kamiya, Fumio Goto, Shun Kaneko, Masato Miyoshi, Tomoyuki Tsunoda, Yu Asano, Fukiko Kawai-Kitahata, Sayuri Nitta, Toru Nakata, Ryuichi Okamoto, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Yasuhiro Asahina, Tomoyuki Yamaguchi, Naohiko Koshikawa, Motoharu Seiki, Hiromitsu Nakauchi, Mamoru Watanabe. Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cells. Biochem. Biophys. Res. Commun. 2016.01; 469 (4): 1062-1068. ( PubMed, DOI )

Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shinji Tanaka, Sei Kakinuma, Miyako Murakawa, Sayuri Nitta, Takako Watanabe, Satoshi Otani, Miki Taniguchi, Fumio Goto, Hiroko Nagata, Shun Kaneko, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Seishin Azuma, Yasuhiro Itsui, Mina Nakagawa, Minoru Tanabe, Shinichi Takano, Mitsuharu Fukasawa, Minoru Sakamoto, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features. J Gastroenterol. 2015.11; ( PubMed, DOI )

Seishin Azuma, Yasuhiro Asahina, Yuki Nishimura-Sakurai, Sei Kakinuma, Shun Kaneko, Hiroko Nagata, Fumio Goto, Satoshi Ootani, Fukiko Kawai-Kitahata, Miki Taniguchi, Miyako Murakawa, Takako Watanabe, Megumi Tasaka-Fujita, Yasuhiro Itsui, Mina Nakagawa, Mamoru Watanabe. Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma. Hepatol Res. 2015.07; ( PubMed, DOI )

Kaneko Shun, Asahina Yasuhiro, Murakawa Miyako, Okamoto Ryuichi. 慢性B型肝炎患者において肝スティフネスは疾患進行と肝細胞癌予測リスクスコアを層別化する(Liver stiffness stratify the disease progression and hepatocellular carcinoma predictive risk score on chronic hepatitis B patients). 肝臓 2023.09.01

Takahama Shokichi, Yoshio Sachiyo, Murakami Hirotomo, Akita Hirofumi, Nogimori Takuto, Kaneko Shun, Kurosaki Masayuki, Asahina Yasuhiro, Sakamori Ryotaro, Takehara Tetsuo, Kanto Tatsuya, Yamamoto Takuya. ヒト免疫学(Immunointervention)　HBc特異的CD8 T細胞の量的・質的差異がB型肝炎患者のHBsAg量に影響を与える(Human Immunology(Immunointervention)　Quantitative and qualitative differences in HBc-specific CD8 T cells could impact the level of HBsAg in Hepatitis B patients). 日本免疫学会総会・学術集会記録 2022.11.01

Shun Kaneko. The risk factor of hepatocellular carcinoma in chronic hepatitis B patients on nucleos(t)ide analogues therapy. The 6th Joint Session between TDDW - JDDW – KDDW 2022.09.24

Kaneko Shun, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Hayakawa Yuka, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Nakanishi Hiroyuki, Tsuchiya Kaoru, Izumi Namiki. HBe抗原陰性B型慢性肝炎患者における疾患進行のマーカーおよび肝細胞癌の予測リスクとしてのB型肝炎コア関連抗原(Hepatitis B core-related antigen as a marker for disease progression and predictive risk of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients). 日本消化器がん検診学会雑誌 2021.10.01

Inada Kento, Nakanishi Hiroyuki, Muto Tomohiro, Kirino Sakura, Yamashita Koji, Osawa Leona, Sekiguchi Shuhei, Hayakawa Yuka, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Itakura Jun, Takahashi Yuka, Tsuchiya Kaoru, Kurosaki Masayuki, Izumi Namiki. 微小粘膜下浸潤を予測するための狭帯域光観察による拡大内視鏡検査によって発見された早期胃がんにおける拡張血管の臨床的有用性について(Clinical usefulness of dilated vessels in early gastric cancer found by magnifying endoscopy with narrow-band imaging for predicting minute submucosal invasion). Gastroenterological Endoscopy 2021.10.01

Inada Kento, Nakanishi Hiroyuki, Muto Tomohiro, Kirino Sakura, Yamashita Koji, Osawa Leona, Sekiguchi Shuhei, Hayakawa Yuka, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Itakura Jun, Takahashi Yuka, Tsuchiya Kaoru, Kurosaki Masayuki, Izumi Namiki. NBI併用拡大内視鏡検査で発見された早期胃癌の微小粘膜下浸潤の予測における拡張血管の臨床的有用性(Clinical usefulness of dilated vessels in early gastric cancer found by magnifying endoscopy with narrow-band imaging for predicting minute submucosal invasion). 日本消化器病学会雑誌 2021.10.01

Kaneko Shun, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Hayakawa Yuka, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Nakanishi Hiroyuki, Tsuchiya Kaoru, Izumi Namiki. HBe抗原陰性B型慢性肝炎患者における病勢進行のマーカーおよび肝細胞癌の予測リスク因子としてのB型肝炎コア関連抗原(Hepatitis B core-related antigen as a marker for disease progression and predictive risk of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients). 日本消化器病学会雑誌 2021.10.01

Inada Kento, Nakanishi Hiroyuki, Muto Tomohiro, Kirino Sakura, Yamashita Koji, Osawa Leona, Sekiguchi Shuhei, Hayakawa Yuka, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Itakura Jun, Takahashi Yuka, Tsuchiya Kaoru, Kurosaki Masayuki, Izumi Namiki. 狭帯域画像を用いた拡大内視鏡検査で発見された早期胃癌の拡張血管の微小粘膜下浸潤予測に関する臨床的有用性(Clinical usefulness of dilated vessels in early gastric cancer found by magnifying endoscopy with narrow-band imaging for predicting minute submucosal invasion). 日本消化器がん検診学会雑誌 2021.10.01

Kaneko Shun, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Hayakawa Yuka, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Nakanishi Hiroyuki, Tsuchiya Kaoru, Izumi Namiki. HBe抗原陰性B型慢性肝炎患者における疾患進行のマーカーおよび肝細胞癌の予測リスクとしてのB型肝炎コア関連抗原について(Hepatitis B core-related antigen as a marker for disease progression and predictive risk of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients). 肝臓 2021.09.01

Kaneko Shun, Kurosaki Masayuki, Izumi Namiki. B型肝炎診療の最先端2020(The latest in the prevention and treatment of hepatitis B: 2020 update)　Nucleos(t)ide analogue投与中の血清中HBV-DNA量により層別化したB型慢性肝炎患者の肝細胞癌リスク(Serum HBV-DNA during nucleos(t)ide analogues therapy stratifies hepatocellular carcinoma risk on chronic hepatitis B patients). 肝臓 2020.09.01

Shun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, Jun Itakura, Sakura Kirino, Leona Osawa, Keiya Watakabe, Mao Okada, Wan Wang, Takao Shimizu, Mayu Higuchi, Kenta Takaura, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yuka Takahashi, Namiki Izumi. Efficacy and safety of switching therapy from tenofovir disoproxil fumarate to tenofovir alafenamide for hepatitis B virus infection. 2019 EASL 2019.04.12 Vienna

Nakagawa M, Asahina Y, Nagata H, Kaneko S, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Azuma S, Kakinuma S, Tanaka Y, Watanabe M. Evaluation of an early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C patients treated with All-Oral DAAs - propensity score-matched analysis of a prospective database -. AASLD, The Liver Meeting 2017 2017.10.22 Washington D.C (USA）

Kaneko S, Kakinuma S, Asahina Y, Kamiya A, Miyoshi M, Tsunoda T, Inoue-Shinomiya E, Nitta S, Sato A, Asano Y, Nagata H, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Watanabe M. A novel culture model for coinfection of hepatitis B and hepatitis C viruses using human induced pluripotent stem cell–derived hepatic cells for analyses of changes in host-innate immune responses . AASLD The Liver Meeting 2017 2017.10.22 Washington D.C (USA）

Miyako Murakawa, Yasuhiro Asahina, Mina Nakagawa, Sayuri Nitta, Fukiko Kawai-Kitahata, Hiroko Nagata, Syun Kaneko, Yu Asano, Masato Miyoshi, Tomoyuki Tsunoda, Emi Inoue-Shinomiya, Ayako Sato, Yasuhiro Itsui, Sei Kakinuma, Seishin Azuma, Mamoru Watanabe. On-treatment higher levels of alpha-fetoprotein and M2BPGi are associated with development of hepatocellular carcinoma during nucleos(t)ide analog therapy in patients with HBV chronic infection. AASLD, The Liver Meeting 2017 2017.10.21 Washington DC

Shun Kaneko, Sei Kakinuma, Yasuhiro Asahina, Akihide Kamiya, Masato Miyoshi, Tomoyuki Tsunoda, Sayuri Nitta, Ayako Sato, Yu Asano, Hiroko Nagata, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Mamoru Watanabe. Genetically modified human induced pluripotent stem cell-derived hepatic progenitor-like cell lines as a model for interaction between hepatitis B virus and host cells. AASLD The Liver meeting 2016 2016.11.11 Boston（USA）

Kaneko S, Kakinuma S, Asahina Y, Kamiya A, Nitta S, Tsunoda T, Miyoshi M, Asano Y, Nagata H , Goto F, Otani S, Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Watanabe M. A new model for studying interaction between hepatitis B virus and host cells derived from human induced pluripotent stem cells. EASL The International Liver Congress 2016 2016.04.14 Barcelona（Spain）

Kaneko S, Kakinuma S, Asahina Y, Kamiya A, Nitta S, Tsunoda T, Miyoshi M, Asano Y, Nagata H, Goto F, Otani S, Kitahata F, Murakawa M , Itsui Y, Nakagawa M, Azuma S, Watanabe M. A Model for Interaction between HBV and Host Cells Derived from Human Induced Pluripotent Stem Cells. The 25th Asian Pacific Association for the Study of the Liver 2016.02.22 International Convention Center Pamir, Tokyo（JAPAN）

Kawai-Kitahata F, Asahina Y, Tanaka S, Kakinuma S, Murakawa M, Nitta S, Otani S, Goto F, Nagata H, Kaneko S, Asano Y, Miyoshi M, Tsunoda T, Azuma S, Itsui Y, Nakagawa M, Tanabe M, Maekawa S, Enomoto N, Watanabe M. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma. The 25th Asian Pacific Association for the Study of the Liver 2016.02.22 International Convention Center Pamir, Tokyo（JAPAN）

Shun Kaneko, Sei Kakinuma, Yasuhiro Asahina, Akihide Kamiya, Sayuri Nitta, Tomoyuki Tsunoda, Masato Miyoshi, Hiroko Nagata, Fumio Goto, Satoshi Otani, Miyako Murakawa, Fukiko Kawai-Kitahata, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Mamoru Watanabe. Human induced pluripotent stem cell-derived hepatic progenitor-like cells and hepatocyte-like cells as a model for interaction between hepatitis B virus and host cells. AASLD The Liver Meeting 2015 2015.11.16 San Francisco, CA

Kawai-Kitahata F, Asahina Y, Tanaka S, Kakinuma S, Murakawa M, Nitta S, Watanabe T, Otani S, Goto F, Nagata H, Kaneko S, Azuma S, Itsui Y, Nakagawa M, Tanabe M, Maekawa S, Enomoto N, Watanabe M. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.. AASLD The Liver Meeting 2015 2015.11.14 San Francisco

Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shun Kaneko, Hiroko Nagata, Fumio Goto, Satoshi Otani, Miki Taniguchi, Miyako Murakawa, Sayuri Nitta, Takako Watanabe, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Sei Kakinuma, Shinji Tanaka , Minoru Tanabe, Nobuyuki Enomoto and Mamoru Watanabe. Gene alterations in TERT promoter, CTNNB1, and TP53 are closely associated with development and prognosis of hepatocellular carcinoma : Comprehensive analyses by next generation sequencing technology. The 3rd JSGE International Topic Conference 2015.04.24 仙台